Study finds limited evidence for IL-1 blockers in treating COVID-19
Researchers assess the effectiveness and safety outcomes of interleukin-1 blocking agents in the treatment of COVID-19.
Juan Gaertner Shutterstock World Health Organization Cochrane Database Systematic Reviewsstudy Juan Gaertner Clinical Progression
Source: news-medical.net